Director/PDMR Shareholding

Summary by AI BETAClose X

Renalytix plc announced that on September 29, 2026, investment vehicles connected to Non-Executive Director Christopher Mills purchased 1,166,667 ordinary shares at £0.06 per share, totaling £70,000. Following this transaction, Christopher Mills and associated entities now hold 18,201,690 ordinary shares, representing 2.7% of the company's enlarged share capital. This director dealing indicates continued confidence in the company's prospects.

Disclaimer*

UK 100

Latest directors dealings